Exact Mass: 432.226
Exact Mass Matches: 432.226
Found 307 metabolites which its exact mass value is equals to given mass value 432.226
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Buclizine
Buclizine is only found in individuals that have used or taken this drug. It is an antihistamine of the piperazine derivative family. [Wikipedia]Vomiting (emesis) is essentially a protective mechanism for removing irritant or otherwise harmful substances from the upper GI tract. Emesis or vomiting is controlled by the vomiting centre in the medulla region of the brain, an important part of which is the chemotrigger zone (CTZ). The vomiting centre possesses neurons which are rich in muscarinic cholinergic and histamine containing synapses. These types of neurons are especially involved in transmission from the vestibular apparatus to the vomiting centre. Motion sickness principally involves overstimulation of these pathways due to various sensory stimuli. Hence the action of buclizine which acts to block the histamine receptors in the vomiting centre and thus reduce activity along these pathways. Furthermore since buclizine possesses anti-cholinergic properties as well, the muscarinic receptors are similarly blocked. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Doxapram hydrochloride hydrate
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019141 - Respiratory System Agents
Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate
Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate is found in alcoholic beverages. Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate is present in Riesling wine. Present in Riesling wine. Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate is found in alcoholic beverages.
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate is also known as PA(18:3(6Z,9Z,12Z)/0:0). 1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate is also known as PA(18:3(9Z,12Z,15Z)/0:0). 1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(18:3(6Z,9Z,12Z)/0:0)
LysoPA(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(18:3(6Z,9Z,12Z)/0:0), in particular, consists of one chain of gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(18:3(9Z,12Z,15Z)/0:0)
LysoPA(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(18:3(9Z,12Z,15Z)/0:0), in particular, consists of one chain of alpha-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(1S,4S,5S,7R,10R)-10,11,14-trihydroxyguai-3-one 11-O-beta-D-glucopyranoside|(1S,4S,5S,7R,10R)-10,11,14-Trihydroxyguai-3-one 11-O-??-D-glucopyranoside|(1S,4S,5S,7R,10R)-10,11,14-trihydroxyguaian-3-one 11-O-beta-D-glucopyranoside
1beta,6beta,9alpha,11-tetrahydroxy-trans-eudesm-3-ene-6-O-beta-D-glucopyranoside
2,4,6-tri-O-acetyl-3-O-isobutyryl-1-O-2-methylbutyryl-chiro-inositol
(14R,16R,19S,20R)-(1-hydroxy-16,20-dimethyl-20-(24-methylpent-23-en-21-yl)- 14,15,16,17,18,19-hexahydro-6H-3,16-epoxybenzo[c]chromen-6-yl)(phenyl)methanone|benzophenone-congestiflorone
(1beta,4alphaH,5alpha,10betaH)-2beta,7alpha,8alpha-trihydroxy-10,11-epoxy-guaiane 2-O-beta-D-glucopyranoside|daucuside
2alpha,7,12-trihydroxykessane 2-O-beta-D-glucopyranoside
Ile Ser Val Asp
Buclizine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Ala Glu Ile Thr
Ala Glu Leu Thr
Ala Glu Thr Ile
Ala Glu Thr Leu
Ala Ile Glu Thr
Ala Ile Thr Glu
Ala Lys Asn Thr
Ala Lys Gln Ser
Ala Lys Ser Gln
Ala Lys Thr Asn
Ala Leu Glu Thr
Ala Leu Thr Glu
Ala Asn Lys Thr
Ala Asn Thr Lys
Ala Gln Lys Ser
Ala Gln Ser Lys
Ala Ser Lys Gln
Ala Ser Gln Lys
Ala Thr Glu Ile
Ala Thr Glu Leu
Ala Thr Ile Glu
Ala Thr Lys Asn
Ala Thr Leu Glu
Ala Thr Asn Lys
Asp Ile Ser Val
Asp Ile Val Ser
Asp Leu Ser Val
Asp Leu Val Ser
Asp Ser Ile Val
Asp Ser Leu Val
Asp Ser Val Ile
Asp Ser Val Leu
Asp Thr Val Val
Asp Val Ile Ser
Asp Val Leu Ser
Asp Val Ser Ile
Asp Val Ser Leu
Asp Val Thr Val
Asp Val Val Thr
Glu Ala Ile Thr
Glu Ala Leu Thr
Glu Ala Thr Ile
Glu Ala Thr Leu
Glu Ile Ala Thr
Glu Ile Thr Ala
Glu Leu Ala Thr
Glu Leu Thr Ala
Glu Ser Val Val
Glu Thr Ala Ile
Glu Thr Ala Leu
Glu Thr Ile Ala
Glu Thr Leu Ala
Glu Val Ser Val
Glu Val Val Ser
Gly Lys Gln Thr
Gly Lys Thr Gln
Gly Gln Lys Thr
Gly Gln Thr Lys
Gly Thr Lys Gln
Gly Thr Gln Lys
Ile Ala Glu Thr
Ile Ala Thr Glu
Ile Asp Ser Val
Ile Asp Val Ser
Ile Glu Ala Thr
Ile Glu Thr Ala
Ile Ser Asp Val
Ile Thr Ala Glu
Ile Thr Glu Ala
Ile Val Asp Ser
Ile Val Ser Asp
Lys Ala Asn Thr
Lys Ala Gln Ser
Lys Ala Ser Gln
Lys Ala Thr Asn
Lys Gly Gln Thr
Lys Gly Thr Gln
Lys Asn Ala Thr
Lys Asn Thr Ala
Lys Gln Ala Ser
Lys Gln Gly Thr
Lys Gln Ser Ala
Lys Gln Thr Gly
Lys Ser Ala Gln
Lys Ser Gln Ala
Lys Thr Ala Asn
Lys Thr Gly Gln
Lys Thr Asn Ala
Lys Thr Gln Gly
Leu Ala Glu Thr
Leu Ala Thr Glu
Leu Asp Ser Val
Leu Asp Val Ser
Leu Glu Ala Thr
Leu Glu Thr Ala
Leu Ser Asp Val
Leu Ser Val Asp
Leu Thr Ala Glu
Leu Thr Glu Ala
Leu Val Asp Ser
Leu Val Ser Asp
Asn Ala Lys Thr
Asn Ala Thr Lys
Asn Lys Ala Thr
Asn Lys Thr Ala
Asn Thr Ala Lys
Asn Thr Lys Ala
Gln Ala Lys Ser
Gln Ala Ser Lys
Gln Gly Lys Thr
Gln Gly Thr Lys
Gln Lys Ala Ser
Gln Lys Gly Thr
Gln Lys Ser Ala
Gln Lys Thr Gly
Gln Ser Ala Lys
Gln Ser Lys Ala
Gln Thr Gly Lys
Gln Thr Lys Gly
Ser Ala Lys Gln
Ser Ala Gln Lys
Ser Asp Ile Val
Ser Asp Leu Val
Ser Asp Val Ile
Ser Asp Val Leu
Ser Glu Val Val
Ser Ile Asp Val
Ser Ile Val Asp
Ser Lys Ala Gln
Ser Lys Gln Ala
Ser Leu Asp Val
Ser Leu Val Asp
Ser Gln Ala Lys
Ser Gln Lys Ala
Ser Val Asp Ile
Ser Val Asp Leu
Ser Val Glu Val
Ser Val Ile Asp
Ser Val Leu Asp
Ser Val Val Glu
Thr Ala Glu Ile
Thr Ala Glu Leu
Thr Ala Ile Glu
Thr Ala Lys Asn
Thr Ala Leu Glu
Thr Ala Asn Lys
Thr Asp Val Val
Thr Glu Ala Ile
Thr Glu Ala Leu
Thr Glu Ile Ala
Thr Glu Leu Ala
Thr Gly Lys Gln
Thr Gly Gln Lys
Thr Ile Ala Glu
Thr Ile Glu Ala
Thr Lys Ala Asn
Thr Lys Gly Gln
Thr Lys Asn Ala
Thr Lys Gln Gly
Thr Leu Ala Glu
Thr Leu Glu Ala
Thr Asn Ala Lys
Thr Asn Lys Ala
Thr Gln Gly Lys
Thr Gln Lys Gly
Thr Val Asp Val
Thr Val Val Asp
Val Asp Ile Ser
Val Asp Leu Ser
Val Asp Ser Ile
Val Asp Ser Leu
Val Asp Thr Val
Val Asp Val Thr
Val Glu Ser Val
Val Glu Val Ser
Val Ile Asp Ser
Val Ile Ser Asp
Val Leu Asp Ser
Val Leu Ser Asp
Val Ser Asp Ile
Val Ser Asp Leu
Val Ser Glu Val
Val Ser Ile Asp
Val Ser Leu Asp
Val Ser Val Glu
Val Thr Asp Val
Val Thr Val Asp
Val Val Asp Thr
Val Val Glu Ser
Val Val Ser Glu
Val Val Thr Asp
Glucosyl (2E,6E,10x)-10,11-dihydroxy-2,6-farnesadienoate
1-N-Boc-4-(3-Cbz-amino-3-methoxycarbonylallyl)piperidine
(R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol
PF-04995274 is a potent, high-affinity, orally active and partial serotonin 4 receptor (5-HT4R) agonist. PF-04995274 has an EC50 range of 0.26-0.47 nM for human 5-HT4A/4B/4D/4E (Ki range of 0.15-0.46 nM), and has an EC50 range of 0.59-0.65 nM for rat 5-HT4S/4L/4E (Ki of 0.30 nM for rat 5-HT4S). PF-04995274 is brain penetrant and can be used for cognitive disorders associated with Alzheimer's disease[1][2][3].
Enadoline hydrochloride
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D020011 - Protective Agents
Platensimide A
A polycyclic cage compound that is a carboxamide obtained by the formal condensation of the amino group of 4-(acetylamino)-2-aminobutanoic acid with the carboxy group of the oxatetracyclic cage component. It is isolated from Streptomyces platensis.
1,4,8,11-tetraazacyclotetradecane-N,N,N,N-tetraacetic acid
1,1-(1,3-Phenylenebis(propane-2,2-diyl))bis(3-(pyridin-3-yl)urea)
N-[3-(1-azepanyl)propyl]-2-(4-morpholinyl)-3-oxo-4H-1,4-benzothiazine-6-carboxamide
(3R,4S,6R)-N-[(2-methoxyphenyl)methyl]-6-[(4-pyridin-2-yltriazol-1-yl)methyl]-1-azabicyclo[2.2.2]octane-3-carboxamide
1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride hydrate
2-fluoro-N-[(2R,3S,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
2-fluoro-N-[(2R,3S,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
2-fluoro-N-[(2S,3S,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
[(8S,9S,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
2-fluoro-N-[(2S,3R,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
2-fluoro-N-[(2S,3R,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
2-fluoro-N-[(2R,3R,6R)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
2-fluoro-N-[(2S,3S,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
2-fluoro-N-[(2R,3R,6S)-6-[2-[4-(1-hydroxycyclopentyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzamide
[(8S,9R,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9S,10R)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9S,10S)-9-[4-(2-fluorophenyl)phenyl]-6-(5-pyrimidinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
1-Linoleoylglycerone 3-phosphate
A 1-acylglycerone 3-phosphate in which the acyl group is specified as linoleoyl.
2-Hydroxy-3-(phosphonooxy)propyl (9Z,12Z,15Z)-9,12,15-octadecatrienoate
1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate
Asp-Leu-Val-Ser
A tetrapeptide composed of L-aspartic acid, L-leucine, L-valine and L-serine units joined in sequence.
1-Oleoylglycerone 3-phosphate(2-)
A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoylglycerone 3-phosphate; major species at pH 7.3.
1-(gamma-linolenoyl)-sn-glycero-3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as gamma-linolenoyl (6Z,9Z,12Z-octadecatrienoyl).
1-linolenoyl-sn-glycero-3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as linolenoyl (9Z,12Z,15Z-octadecatrienoyl).
1-Linoleoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-linoleoyl-sn-glycero-3-phosphate.
(2s,3r,4s,5s,6r)-2-{[(1r,2r,4s)-2,4-dihydroxy-2-[(1e,3e)-5-hydroxy-3-methylpenta-1,3-dien-1-yl]-1,3,3-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[5-hydroxy-4a-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-8-methyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,5s,8ar)-5-hydroxy-4a-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-8-methylidene-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-ethylidene-2-{9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
(3r,4ar,5s,6s,8ar)-6-hydroxy-3-(2-hydroxypropan-2-yl)-5,8a-dimethyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydro-1h-naphthalen-2-one
2-{[5-hydroxy-4a-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-8-methylidene-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1r,2r,3r,5r,6r,8s,12s)-8,12-dihydroxy-1,5,9,9-tetramethyl-10-oxatricyclo[6.2.2.0²,⁶]dodecan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1r,2r,4s)-2,4-dihydroxy-2-(5-hydroxy-3-methylpenta-1,3-dien-1-yl)-1,3,3-trimethylcyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-eudesmene-1,6,11,14-tetrol; (1α,5β,6β,10α)-form,6-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN008540","Ingredient_name": "3-eudesmene-1,6,11,14-tetrol; (1\u03b1,5\u03b2,6\u03b2,10\u03b1)-form,6-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O9","Ingredient_Smile": "NA","Ingredient_weight": "432.51","OB_score": "NA","CAS_id": "202278-90-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8132","PubChem_id": "NA","DrugBank_id": "NA"}
4,14-epoxy-1,6,11-eudesmanetriol; (1α,4α,5β,6β,10α)-form,6-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN009819","Ingredient_name": "4,14-epoxy-1,6,11-eudesmanetriol; (1\u03b1,4\u03b1,5\u03b2,6\u03b2,10\u03b1)-form,6-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O9","Ingredient_Smile": "NA","Ingredient_weight": "432.51","OB_score": "NA","CAS_id": "202278-88-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7937","PubChem_id": "NA","DrugBank_id": "NA"}
4(15)-eudesmene-1,6,11,14-tetrol; (1α,5β,6β,10α)-form,6-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN009831","Ingredient_name": "4(15)-eudesmene-1,6,11,14-tetrol; (1\u03b1,5\u03b2,6\u03b2,10\u03b1)-form,6-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O9","Ingredient_Smile": "NA","Ingredient_weight": "432.51","OB_score": "NA","CAS_id": "202278-89-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7975","PubChem_id": "NA","DrugBank_id": "NA"}